Back to mobile site

Genzyme (GENZ) Reports Q3 Miss; Narrows Q4 EPS Outlook

October 20, 2010 9:24 AM EDT Send to a Friend
Genzyme (NYSE: GENZ) Reports Q3 EPS of $0.42, ex-items, 9 cents lower ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login